Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients.
about
Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@en
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@nl
type
label
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@en
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@nl
prefLabel
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@en
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@nl
P2093
P2860
P1433
P1476
Circulating miR-210 and miR-22 ...... alpha therapy of CHB patients.
@en
P2093
Bisheng Shi
Jiming Zhang
Liang Chen
Maya Kozlowski
Weixia Wang
Xiaonan Zhang
Xinxin Zhang
P2860
P2888
P356
10.1038/S41598-017-15594-0
P407
P577
2017-11-15T00:00:00Z